AT

Akebia Therapeutics

Biotechnology · Cambridge, Massachusetts, United States · Founded 2007

About

Akebia Therapeutics is fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine. Research output of 200-300 works, primarily in Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology.

Company details may include data from People Data Labs, licensed CC BY 4.0.